Find investors
← Back to all investors
Aaron Collins
ResearchedPrivate Equity (mid-market) / Angel Investor (personal capacity)

Aaron Collins

Director (Investment) · Bridgepoint Group

Private Equity Investor / Angel InvestorMid-market buyouts (Bridgepoint); Seed / Early Stage (angel investments)Consumer, Business & Financial Services, Healthcare, TechnologyLondon, United Kingdom
Pitch Aaron

Get their honest, personalized take on your startup.

Sign in to pitch Aaron

At a glance

Title
Director (Investment)
Role
Private Equity Investor / Angel Investor
Firm
Bridgepoint Group
Firm Type
Private Equity (mid-market) / Angel Investor (personal capacity)
Investment Stage
Mid-market buyouts (Bridgepoint); Seed / Early Stage (angel investments)
Sector Focus
Consumer, Business & Financial Services, Healthcare, Technology
Location
London, United Kingdom
Current Fund
Bridgepoint Europe VII (previously Europe VI, ~EUR 5.7bn)

Background

Aaron Collins is a Director at Bridgepoint Group, one of Europe's leading mid-market private equity firms headquartered in London with approximately EUR 67 billion in assets under management. He joined Bridgepoint in 2015 after several years as a management consultant at Bain & Company, where he worked within the Private Equity Group advising on deal sourcing, due diligence, and portfolio company strategy. At Bridgepoint, he sits on the London deal team and is a member of both the Business & Financial Services and Consumer sector teams.

Collins holds a Master's degree (MPhil) in Economics from the University of Cambridge (2010-2011) and a Bachelor's degree (BSc) in Economics with First Class Honours from the University of Bristol (2007-2010). His academic grounding in economics complements his investment career, where he has been involved in transactions across multiple sectors and geographies.

Outside of his primary role at Bridgepoint, Collins is an active angel investor in and advisor to several early-stage technology businesses. His personal portfolio includes investments in companies such as Bezos.AI, Tillit, Sanno, Robin AI, Fable Data, Freetrade, and Flynotes, reflecting a strong interest in fintech, AI/machine learning, and data-driven startups. This dual track -- large-cap private equity by day and seed-stage angel investing alongside -- gives him an unusually broad perspective across the company lifecycle.

Investment Thesis & Focus

At Bridgepoint, Collins focuses on mid-market growth businesses in the consumer and business services sectors across Europe. Bridgepoint's strategy emphasises growth-oriented, collaborative investing rather than financial engineering, with typical hold periods of 4-7 years. The firm targets companies with strong market positions that can benefit from international expansion, digital transformation, and product portfolio development.

In his personal angel investing capacity, Collins gravitates toward early-stage technology companies, particularly those applying artificial intelligence, data analytics, and fintech innovation. He appears to favour founding teams building technology-enabled platforms that can disrupt or modernise traditional industries.

Notable Investments

  • RoC Skincare -- acquisition completed February 2024 (~$500M); Collins currently serves on the board
  • Deliveroo -- Series E lead investor
  • Fishawack (healthcare communications)
  • Burger King UK
  • Zenith
  • CVL
  • Sapec Agro / Rovensa (agrochemicals)
  • Exova (testing and advisory services)
  • Hobbycraft (portfolio board responsibility)
  • Bezos.AI
  • Tillit
  • Sanno
  • Robin AI (AI-powered contract review)
  • Fable Data
  • Freetrade (commission-free investing platform)
  • Flynotes

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.